Chen; Frank Xing

Patent Applications and Registrations

Patent applications and USPTO patent grants for Chen; Frank Xing.The latest application filed is for "methods of manufacturing of niraparib".

Company Profile

1.9.12

Chen; Frank Xing - Plainsboro NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods Of Manufacturing Of Niraparib App 20220041575 - Stewart; Alistair ; et al.	2022-02-10
Methods of manufacturing of niraparib Grant 11,161,834 - Stewart , et al. November 2, 2	2021-11-02
Methods Of Manufacturing Of Niraparib App 20200055837 - Stewart; Alistair ; et al.	2020-02-20
Process and intermediates for the synthesis of 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaz- a-spiro[4.5]decan-2-one compounds Grant 9,822,116 - Wu , et al. November 21, 2	2017-11-21
Process And Intermediates For The Synthesis Of 8-[-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one Compounds App 20160145256 - Wu; George G. ; et al.	2016-05-26
Process and intermediates for the synthesis of 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaz- a-spiro[4.5]decan-2-one compounds Grant 9,249,144 - Wu , et al. February 2, 2	2016-02-02
Process and Intermediates for the Synthesis of 8-[-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one Compounds App 20140031549 - Wu; George G. ; et al.	2014-01-30
Exo- And Diastereo- Selective Synthesis Of Himbacine Analogs App 20120296093 - Wu; George ; et al.	2012-11-22
Process and intermediates for the synthesis of (3-alkyl-5-piperidin-1-yl-3,3a-dihydro-pyrazolo[1,5-a]pyrimidin-7-yl)-ami- no derivatives and intermediates Grant 8,076,479 - Chen , et al. December 13, 2	2011-12-13
Exo- And Diastereo- Selective Synthesis Of Himbacine Analogs App 20110251392 - Wu; George ; et al.	2011-10-13
Process and intermediates for the Synthesis of heterocyclic Substituted Piperazines with CXCR3 Antagonist Activity App 20110124867 - Chen; Frank Xing ; et al.	2011-05-26
Process for resolving chiral piperidine alcohol and process for synthesis of pyrazolo[1,5-a] pyrimidine derivatives using same Grant 7,786,306 - Chen , et al. August 31, 2	2010-08-31
Exo- And Diastereo- Selective Syntheses Of Himbacine Analogs App 20090281321 - Wu; George ; et al.	2009-11-12
Exo- and diastereo- selective syntheses of himbacine analogs Grant 7,605,275 - Chen , et al. October 20, 2	2009-10-20
Enantioselective process Grant 7,582,763 - Chen , et al. September 1, 2	2009-09-01
Oxidation process for the preparation of N-[3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]-3-{N-[(tert-butylamino)c- arbonyl]-3-methyl-L-valyl}-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carbox- amide and related compounds Grant 7,528,263 - Wu , et al. May 5, 2	2009-05-05
Process and intermediates for the synthesis of (3-alkyl-5-piperidin-1-yl-3,3a-dihydro-pyrazolo[1,5-a]pyrimidin-7-yl)-ami- no derivatives and intermediates App 20080058518 - Chen; Frank Xing ; et al.	2008-03-06
Process for resolving chiral piperidine alcohol and process for synthesis of pyrazolo[1,5-a] pyrimidine derivatives using same App 20080051579 - Chen; Frank Xing ; et al.	2008-02-28
Exo- and diastereo- selective syntheses of himbacine analogs App 20060247450 - Wu; George ; et al.	2006-11-02
Synthesis of intermediates useful in preparing tricyclic compounds App 20020077331 - Bernard, Charles F. ; et al.	2002-06-20
Enantioselective alkylation of tricyclic compounds Grant 6,307,048 - Kuo , et al. October 23, 2	2001-10-23

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.